Research Article: Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
Introduction:
Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third reason of cancer-related mortality worldwide. Hepatitis B virus (HBV) infection is the major risk factor for HCC, especially in Asia, and can drive carcinogenesis in the human genome through integrations. Moreover, a high HBV virus load has been considered as an independent risk factor for the progression of HCC. Several studies have shown that antiviral treatment is associated with the improved prognosis of HBV-related HCC patients…
Read more